Previous close | 0.4815 |
Open | 0.3900 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.3900 - 0.3900 |
52-week range | 0.3900 - 0.7630 |
Volume | |
Avg. volume | 442 |
Market cap | 11.971M |
Beta (5Y monthly) | 1.25 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.3530 |
Earnings date | 02 Oct 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PARIS & BOSTON, July 25, 2024--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces its unaudited sales and achievements for the second quarter and first half 2024, ended June 30, 2024.
PARIS, July 17, 2024-- Regulatory News: Under the liquidity contract between the company MAUNA KEA TECHNOLOGIES (Paris:ALMKT) and the brokerage firm Gilbert Dupont, the following resources appeared on the liquidity account on June 28, 2024:
PARIS, July 04, 2024--Regulatory News: Mauna Kea Technologies (Paris:ALMKT):